This contract expires in 116 days (Sep 30, 2026).
CERUS CORPORATION - CERUS - DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT). IGF::OT::IGF
Key Details
Description
CERUS - DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT). IGF::OT::IGF
Context & Analysis
On Feb 20, 2026, Department of Health and Human Services obligated $185,466,763.57 to CERUS CORPORATION for cerus - development and implementation of pathogen reduction technology (prt). igf::ot::igf. The award is classified under NAICS 541711 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY and issued as a cost no fee contract. Competition extent: full and open competition with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in CONCORD, CA. The contract is scheduled through Sep 30, 2026 — approximately 4 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541711 — related awards are listed below.
Contractor Information
Similar Awards
THE MEDICINE COMPANY - ADVANCE THE DEVELOPMENT OF A PORTFOLIO OF ANTI-INFECTIVE PROGRAMS. IGF::OT::IGF
MEDICINES COMPANY, THE
$98.1M
IGF::OT::IGF
JANSSEN VACCINES & PREVENTION B.V.
$48.9M
IGF::OT::IGF - DNAE / PATHOGEN IDENTIFICATION FROM SPECIMEN, VIA CAPTURE, EXTRACTION AND SEQUENCING (PISCES)
DNAE GROUP HOLDINGS LIMITED
$43.4M
AUTOGRAFT-SPARING PRODUCTS FOR DEFINITIVE CARE OF BURN INJURIES
AVITA MEDICAL AMERICAS, LLC
$40.8M
IGF::OT::IGF POINT OF CARE BIODOSIMETRY TEST
SRI INTERNATIONAL
$25.5M
Stay Updated
Get notified about new opportunities matching your interests.